LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 932974
BOSTON, MA
Position in REGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$41,075,697
-$14,886,618 QoQ
Shares Held
65,875
-9.1% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#137
of 1,297 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $43,678,237 across 12 Biotechnology names. REGN ranks #1 (94.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
65,875 | $41,075,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,317 | $1,647,653 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,533 | $461,478 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
500 | $268,475 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,000 | $77,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
7,500 | $73,650 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
278 | $32,545 | |
| 8 | BNTX |
BioNTech SE
|
190 | $17,679 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,075,697 | 65,875 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $55,962,315 | 72,430 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $67,133,393 | 86,975 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $51,575,340 | 91,727 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $52,454,325 | 99,913 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $61,186,070 | 96,473 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $75,571,802 | 106,091 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $115,090,806 | 109,481 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $108,970,790 | 103,680 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $84,000,352 | 87,274 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $53,967,407 | 61,446 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $36,141,934 | 43,917 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $12,025,485 | 16,736 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $10,451,642 | 12,720 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $9,088,609 | 12,597 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $8,220,974 | 11,934 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $6,505,385 | 11,005 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $7,621,857 | 10,913 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $6,846,939 | 10,842 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,479,662 | 10,707 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,967,999 | 10,685 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,795,273 | 10,135 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $77,297 | 160 | Shares | Sole | 2021-01-14 | |
| No filing history on record for this holder in this stock. | ||||||